Registration Dossier

Toxicological information

Genetic toxicity: in vitro

Currently viewing:

Administrative data

Endpoint:
in vitro gene mutation study in bacteria
Remarks:
Type of genotoxicity: gene mutation
Type of information:
experimental study
Adequacy of study:
key study
Study period:
2016-06-02 to 2016-06-27
Reliability:
1 (reliable without restriction)
Rationale for reliability incl. deficiencies:
other: GLP guideline study

Data source

Reference
Reference Type:
study report
Title:
Unnamed
Year:
2016
Report Date:
2016

Materials and methods

Test guidelineopen allclose all
Qualifier:
according to
Guideline:
OECD Guideline 471 (Bacterial Reverse Mutation Assay)
Deviations:
no
Qualifier:
according to
Guideline:
EU Method B.13/14 (Mutagenicity - Reverse Mutation Test Using Bacteria)
Deviations:
no
Qualifier:
according to
Guideline:
EPA OPPTS 870.5100 - Bacterial Reverse Mutation Test (August 1998)
Deviations:
no
GLP compliance:
yes (incl. certificate)
Remarks:
Bayerisches Landesamt für Gesundheit und Lebensmittelsicherheit, München, Germany
Type of assay:
bacterial reverse mutation assay

Test material

Reference
Name:
Unnamed
Type:
Constituent
Details on test material:
Name: Sodium oleylamphopolycarboxyglycinate
Chemical Name: active ingredient: Sodium oleylamphopolycarboxyglycinate
CAS No.: active ingredient: 97659-53-5
Batch No.: 1297986
Molecular Weight: 838.87 g/mol
Physical State: liquid
Colour: not mentioned
Density: 1.15 g/cm3
pH Value: 8.5 - 9.5 as 20% solution
Active Components: 29.8% Sodium oleylamphopolycarboxyglycinate
10.4% Water
59.8% NaCl
Purity: 40% estimated
Expiry Date: 02 August 2017
Storage Conditions: room temperature
Safety Precautions: The routine hygienic procedures were sufficient to assure personnel health and safety.

Method

Target gene:
His
Species / strain
Species / strain / cell type:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Additional strain / cell type characteristics:
not specified
Metabolic activation:
with and without
Metabolic activation system:
rat S9 liver microsomal fraction
Test concentrations with justification for top dose:
0.0100, 0.0316, 0.100, 0.316, 1.0, 2.5 and 5.0 µL/plate
A correction factor of 3.36 was applied to consider the active amphoteric ingredient (without sodium salt) of the test item.
Vehicle / solvent:
- Vehicle(s)/solvent(s) used: A. dest.
Controls
Untreated negative controls:
yes
Remarks:
A. dest., Eurofins Lot No. 160510, 160530
Negative solvent / vehicle controls:
yes
Remarks:
A. dest., Eurofins Lot No. 160510, 160530
Positive controls:
yes
Positive control substance:
other:
Remarks:
Positive control without metabolic activation: sodium azide for tester strains TA 100, TA 1535; 4-nitro-o-phenylene-diamine for TA 98, TA 1537; methylmethanesulfonate for TA 102; with metabolic activation: 2-aminoanthracene for all strains
Details on test system and experimental conditions:
METHOD OF APPLICATION: in agar (plate incorporation); preincubation

DURATION
-For the plate incorporation method the following materials were mixed in a test tube and poured over the surface of a minimal agar plate:
100 µL Test solution at each dose level, solvent control, negative control or reference mutagen solution (positive control),
500 µL S9 mix (for testing with metabolic activation) or S9 mix substitution buffer (for testing without metabolic activation),
100 µL Bacteria suspension (cf. Preparation of Bacteria, pre-culture of the strain),
2000 µL Overlay agar.
After solidification the plates were inverted and incubated at 37 °C for at least 48 h in the dark.


- Preincubation period: 60 min; 100 µL of the test item preparation was pre-incubated with the tester strains (100 µL) and sterile buffer or the metabolic activation system (500 µL) for 60 min at 37 °C prior to adding the overlay agar (2000 µL) and pouring onto the surface of a minimal agar plate.
- Exposure duration: at least 48 h; After solidification the plates were inverted and incubated at 37 °C for at least 48 h in the dark.



NUMBER OF REPLICATIONS: For each strain and dose level, including the controls, three plates were used. (In a one case only two plates were evaluated)


DETERMINATION OF CYTOTOXICITY
- Method: clearing or rather diminution of the background lawn or a reduction in the number of revertants down to a mutation factor of approximately ≤ 0.5 in relation to the solvent control

Evaluation criteria:
The Mutation Factor is calculated by dividing the mean value of the revertant counts through the mean values of the solvent control (the exact and not the rounded values are used for calculation).
A test item is considered as mutagenic if:
- a clear and dose-related increase in the number of revertants occurs and/or
- a biologically relevant positive response for at least one of the dose groups occurs
in at least one tester strain with or without metabolic activation.
A biologically relevant increase is described as follows:
- if in tester strains TA 98, TA 100 and TA 102 the number of reversions is at least twice as high
- if in tester strains TA 1535 and TA 1537 the number of reversions is at least three times higher
than the reversion rate of the solvent control.
Statistics:
According to OECD guidelines, the biological relevance of the results is the criterion for the interpretation of results, a statistical evaluation of the results is not regarded as necessary.

Results and discussion

Test results
Species / strain:
S. typhimurium TA 1535, TA 1537, TA 98, TA 100 and TA 102
Metabolic activation:
with and without
Genotoxicity:
negative
Cytotoxicity / choice of top concentrations:
cytotoxicity
Remarks:
experiment I and II
Additional information on results:
No precipitation of the test item was observed in any tester strain used in experiment I and II (with and without metabolic activation).
Toxic effects of the test item were noted in most tester strains evaluated in experiment I and II.
In experiment I toxic effects of the test item were observed in tester strain TA 98 at concentrations of 2.5 µL/plate and higher (without metabolic activation) and at a concentration of 5.0 µL/plate (with metabolic activation). In tester strain TA 100 toxic effects of the test item were noted at concentrations of 2.5 µL/plate and higher (with and without metabolic activation). In tester strain TA 1535 toxic effects of the test item were noted at concentrations of 2.5 µL/plate and higher (without metabolic activation).
In experiment II toxic effects of the test item were noted in tester strain TA 98 at concentrations of 2.5 µL/plate and higher (without metabolic activation) and at a concentration of 5.0 µL/plate (with metabolic activation). In tester strains TA 100 and TA 1535 toxic effects of the test item were noted at concentrations of 1.0 µL/plate and higher (without metabolic activation). In tester strain TA 1537 toxic effects of the test item were observed at a concentration of 5.0 µL/plate (without metabolic activation). In tester strain TA 102 toxic effects of the test item were observed at a concentration of 5.0 µL/plate (with metabolic activation).
No biologically relevant increases in revertant colony numbers of any of the five tester strains were observed following treatment with Sodium oleylamphopolycarboxyglycinate at any concentration level, neither in the presence nor absence of metabolic activation in experiment I and II.
All criteria of validity were met
Remarks on result:
other: all strains/cell types tested
Remarks:
Migrated from field 'Test system'.

Applicant's summary and conclusion

Conclusions:
Interpretation of results (migrated information):
negative

In conclusion, it can be stated that during the described mutagenicity test and under the experimental conditions reported, Sodium oleylamphopolycarboxyglycinate did not cause gene mutations by base pair changes or frameshifts in the genome of the tester strains used.
Therefore, Sodium oleylamphopolycarboxyglycinate is considered to be non-mutagenic in this bacterial reverse mutation assay.
Executive summary:

In a reverse gene mutation assay in bacteria, strains TA 98, TA 100, TA 1535, TA 1537 and TA 102 of Salmonella typhimurium were exposed to Sodium oleylamphopolycarboxyglycinate at concentrations of 0.0100, 0.0316, 0.100, 0.316, 1.0, 2.5 and 5.0 µL/plate (experiment I and II), in the presence and absence of mammalian metabolic activation according to the plate incorporation method (experiment I) and the pre-incubation method (experiment II).

Sodium oleylamphopolycarboxyglycinate was tested up to the limit concentration of 5.0 µL/plate in all tester strains used.

The positive controls induced the appropriate responses in the corresponding strains. There was no evidence of induced mutant colonies over background.

This study is classified as acceptable. This study satisfies the requirement for Test Guideline OPPTS 870.5100; OECD 471 for in vitro mutagenicity (bacterial reverse gene mutation) data.